BioCorRx (BICX) Non-Current Assets (2011 - 2026)
BioCorRx (BICX) recorded Non-Current Assets of $1.3 million in Q1 2026, down 79.1% from $6.24 million a year earlier and down 2.1% from the prior quarter.
Powered by 
Analysis
BioCorRx (BICX) Non-Current Assets (2011 - 2026) Analysis & Trends
At the end of FY2025, BioCorRx reported Non-Current Assets of $1.33 million, up 397.4% from FY2024.
- Annual Non-Current Assets has a five-year compound annual growth rate of 9.4% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $267,945 in FY2024 (+32.8%), $201,768 in FY2023 (-55.1%), $449,684 in FY2022 (-24.0%) and $591,649 in FY2021 (-30.6%).
- The Q1 2026 figure is the lowest quarterly Non-Current Assets since Q4 2024.
- On a year-over-year basis, Non-Current Assets rose in three of the last five quarters, with growth averaging 69.1%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 397.4% in Q4 2025, against a decline of 79.1% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $1.33 million (Q4 2025), $6.07 million (Q3 2025) and $6.15 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | BioCorRx | 3.46 Mn | 2.80 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 1.30 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 6.07 Mn |
| Jun 30, 2025 | 6.15 Mn |
| Mar 31, 2025 | 6.24 Mn |
| Dec 31, 2024 | 267,945.00 |
| Sep 30, 2024 | 290,473.00 |
| Jun 30, 2024 | 306,525.00 |
| Mar 31, 2024 | 165,851.00 |
| Dec 31, 2023 | 201,768.00 |
| Sep 30, 2023 | 288,659.00 |
| Jun 30, 2023 | 327,066.00 |
| Mar 31, 2023 | 364,735.00 |
| Dec 31, 2022 | 449,684.00 |
| Sep 30, 2022 | 486,213.00 |
| Jun 30, 2022 | 521,992.00 |
| Mar 31, 2022 | 557,111.00 |
| Dec 31, 2021 | 591,649.00 |
| Sep 30, 2021 | 613,626.00 |
| Jun 30, 2021 | 764,276.00 |
API Access
BioCorRx Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=BICX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "BICX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=BICX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();